I currently write for Seeking Alpha.
I started investing at a young age because I've never liked working for money. I like sharing ideas, learning from others and having fun in the process.
Follow me on Seeking Alpha @JustinGiles
Hedge funds, portfolio management, active trader, trading mostly US equity mkt via stocks, ETF & options, following closely syndicate calendar for IPOs & secondary deals. Pattern recognition human. Frenchman. Active in markets for more than 15 years.
I own 90% biotech stocks and in general I'm a longterm investor. I buy often stocks when they are less than a dollar and often sell them when they are 2-4 baggers.
My motto for 2014:
"Remember to take profit once in a while "!!
Primary interest is Bio with intriguing pipelines that have large growth potential. I attempt to hold >50% of positions as long unless negative data, mgmt. concerns, or known negative events. Diversify and only trade in spec what you can lose.
Twits ideas 4 my personal use on Biotech & chart trades, but not recommendations on buy or sell.
I fail 99% of the time. You've been warned! Ideas Always be FREE. Follow me on twitter @BiotechMoney18 for more trade ideas.
Full time trader. On Wall St. for over twenty years. Founder long/short hedge fund. Currently manages private accounts and with a long/short strategy. To request my performance, e-mail me at firstname.lastname@example.org
Renaissance Capital provides pre-IPO research and global IPO market analytics to institutional investors. The firm manages portfolios of unseasoned equities through the Renaissance IPO ETF (IPO) and the Renaissance International IPO ETF (IPOS).
Trend follower, portfolio manager, market technician. Former sales trader to hedge funds/institutions, research analyst, prop trader, buy-side head of desk. Only took 25 years to find what works for me. Always learning.